NeuroOne CEO Dave Rosa talks uplisting on Nasdaq, upcoming advancements
December 14, 2021 at 16:38 PM EST
NeuroOne commercialized its first diagnostic brain-scan product in January and uplisted to the Nasdaq in May.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
